| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Aug 24 | CERE Cerevel Therapeutics | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 65,679,781 | 0.00 | 0 |
| 1 Aug 24 | CERE Cerevel Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 10,461 | 0.00 | 0 |
| 1 Aug 24 | CERE Cerevel Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 3,282 | 0.00 | 10,461 |
| 1 Aug 24 | CERE Cerevel Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0 | 80,189 | 0.00 | 0 |
| 5 Jun 24 | CERE Cerevel Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 10,461 | 0.00 | 13,743 |
| 16 Oct 23 | CERE Cerevel Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 22.81 | 5,480,052 | 125.00 mm | 65,679,781 |
